Galectin Therapeutics (GALT) Other Gross PP&E Adjustments (2011 - 2026)
Galectin Therapeutics' quarterly Other Gross PP&E Adjustments came in at -$67000.0 in Q1 2026, down 26.42% year-on-year from -$91051.3 in Q1 2025, and down 1216.67% quarter-over-quarter from $6000.0 in Q4 2025.
Galectin Therapeutics has reported Other Gross PP&E Adjustments for 16 years, with the latest figure at -$67000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 26.42% year-over-year to -$67000.0; the trailing twelve-month figure through Mar 2026 stood at -$285000.0 (up 4.36% YoY), and the FY2025 full-year result was $6000.0, changed N/A from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$67000.0, down from $6000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $34000.0 in Q4 2023, with the low at -$150000.0 in Q3 2023.
- Average Other Gross PP&E Adjustments over 5 years is -$74125.0, with a median of -$87000.0 recorded in 2022.
- Peak annual rise in Other Gross PP&E Adjustments reached 277.78% in 2023, while the deepest fall reached 57.78% in 2023.
- Tracing GALT's Other Gross PP&E Adjustments over 5 years: stood at $9000.0 in 2022, then surged by 277.78% to $34000.0 in 2023, then tumbled by 382.35% to -$96000.0 in 2024, then jumped by 106.25% to $6000.0 in 2025, then sank by 1216.67% to -$67000.0 in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$67000.0 (Q1 2026), $6000.0 (Q4 2025), and -$94000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -67,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67,000.00 |
| Mar 31, 2026 | -67,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Dec 31, 2025 | 6,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Sep 30, 2025 | -94,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Mar 31, 2025 | -53,000.00 |
| Sep 30, 2024 | -96,000.00 |
| Sep 30, 2024 | -96,000.00 |
| Jun 30, 2024 | -65,000.00 |
| Jun 30, 2024 | -65,000.00 |
| Mar 31, 2024 | -84,000.00 |
| Mar 31, 2024 | -84,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | -150,000.00 |
| Sep 30, 2023 | -150,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Jun 30, 2023 | -100,000.00 |
| Mar 31, 2023 | -142,000.00 |
| Mar 31, 2023 | -142,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Dec 31, 2022 | 9,000.00 |
| Sep 30, 2022 | -123,000.00 |
| Sep 30, 2022 | -123,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -90,000.00 |
| Mar 31, 2022 | -90,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | -127,000.00 |
| Sep 30, 2021 | -127,000.00 |
| Dec 31, 2020 | -48,000.00 |
| Dec 31, 2020 | -48,000.00 |
| Dec 31, 2019 | 74,000.00 |
| Dec 31, 2019 | 74,000.00 |
| Dec 31, 2018 | 74,000.00 |
| Dec 31, 2018 | 74,000.00 |
| Dec 31, 2017 | 74,000.00 |
| Dec 31, 2017 | 74,000.00 |
| Dec 31, 2016 | 74,000.00 |
| Dec 31, 2016 | 74,000.00 |
| Dec 31, 2015 | 74,000.00 |
| Dec 31, 2015 | 74,000.00 |
| Sep 30, 2015 | -233,000.00 |
| Sep 30, 2015 | -233,000.00 |
| Jun 30, 2015 | -255,000.00 |
| Jun 30, 2015 | -255,000.00 |
| Mar 31, 2015 | -83,000.00 |
| Mar 31, 2015 | -83,000.00 |
| Dec 31, 2014 | -44,000.00 |
| Dec 31, 2014 | -44,000.00 |
| Sep 30, 2014 | -96,000.00 |
| Sep 30, 2014 | -96,000.00 |
| Jun 30, 2014 | -101,000.00 |
| Jun 30, 2014 | -101,000.00 |
| Mar 31, 2014 | -173,000.00 |
| Mar 31, 2014 | -173,000.00 |
| Dec 31, 2013 | -29,000.00 |
| Dec 31, 2013 | -29,000.00 |
| Sep 30, 2013 | -115,000.00 |
| Sep 30, 2013 | -115,000.00 |
| Jun 30, 2013 | -83,000.00 |
| Jun 30, 2013 | -83,000.00 |
| Mar 31, 2013 | -80,000.00 |
| Mar 31, 2013 | -80,000.00 |
| Dec 31, 2012 | -35,000.00 |
| Dec 31, 2012 | -35,000.00 |
| Sep 30, 2012 | -90,000.00 |
| Sep 30, 2012 | -90,000.00 |
| Jun 30, 2012 | -71,000.00 |
| Jun 30, 2012 | -71,000.00 |
| Dec 31, 2011 | 252,000.00 |
| Dec 31, 2011 | 252,000.00 |